Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Ipsen Biopharmaceuticals, Inc.

NDC labeler code: 15054

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

17Products (NDC)

Prescription medicines

FDA applications for these products

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
ApprovedApplicationMedicineSponsor
June 10, 2024NDA218860 Elafibranor
IQIRVO
Ipsen
August 16, 2023NDA215559 Palovarotene
SOHONOS
Ipsen
July 20, 2021NDA215498 Odevixibat
BYLVAY
Ipsen
October 22, 2015NDA207793 Irinotecan hydrochloride
ONIVYDE
Ipsen
April 29, 2009BLA125274 Incobotulinumtoxina
DYSPORT
Ipsen Biopharm Ltd
August 30, 2007NDA022074 Lanreotide acetate
SOMATULINE DEPOT
Ipsen Pharma
August 30, 2005BLA021839 Mecasermin
INCRELEX
Ipsen Inc

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

No recall of these products (by NDC code) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026

FDA Enforcement Report search → · Report an error →